Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
United Therapeutics Corp (UTHR)  
$270.45 2.73 (1.02%) as of 4:30 Thu 5/30


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 47,262,000
Market Cap: 12.78(B)
Last Volume: 562,747 Avg Vol: 421,328
52 Week Range: $205.19 - $276.5
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:

    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   United Therapeutics is a biotechnology company. Through its subsidiary, Lung Biotechnology PBC, Co. is focused on addressing the acute national shortage of transplantable lungs and other organs with a variety of technologies that either delay the need for such organs or expand the supply. Co. markets and sells the following commercial therapies to treat pulmonary arterial hypertension: Remodulin® (treprostinil) Injection; Tyvaso® (treprostinil) Inhalation Solution; Orenitram® (treprostinil) Extended-Release Tablets; and Adcirca® (tadalafil) Tablets. In the U.S., Co. also markets and sells an oncology product, Unituxin® (dinutuximab) Injection, for the treatment of high-risk neuroblastoma.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 577,395 619,080 681,963 1,833,148
Total Sell Value $140,716,560 $150,163,103 $164,291,315 $450,661,443
Total People Sold 8 8 8 10
Total Sell Transactions 69 79 91 260
End Date 2024-02-29 2023-11-28 2023-05-30 2022-05-30

   
Records found: 5060
  Page 7 of 203  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Mahon Paul A EVP & GENERAL COUNSEL   •       –      –    2024-03-07 4 OE $117.76 $706,560 D/D 6,000 42,599     -
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2024-03-06 4 AS $230.28 $3,543,793 D/D (15,000) 130 15%     
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2024-03-06 4 OE $129.49 $1,942,350 D/D 15,000 15,130     -
   Thompson Tommy G   –       •      –    2024-03-06 4 D $236.97 $473,940 D/D (2,000) 8,480     -
   Thompson Tommy G   –       •      –    2024-03-06 4 OE $88.03 $176,060 D/D 2,000 10,480     -
   Giltner Richard   –       •      –    2024-03-06 4 D $236.97 $2,369,700 D/D (10,000) 15,620     -
   Giltner Richard   –       •      –    2024-03-06 4 OE $88.03 $880,300 D/D 10,000 25,620     -
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2024-03-05 4 AS $230.36 $1,454,886 D/D (6,300) 130 19%     
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2024-03-05 4 OE $129.49 $815,787 D/D 6,300 6,430     -
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2024-03-04 4 AS $230.58 $212,071 D/D (915) 130 19%     
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2024-03-04 4 OE $129.49 $118,483 D/D 915 1,045     -
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2024-03-01 4 AS $231.11 $3,493,352 D/D (15,000) 130 18%     
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2024-03-01 4 OE $129.49 $1,942,350 D/D 15,000 15,130     -
   Thompson Tommy G   –       •      –    2024-03-01 4 D $231.92 $463,840 D/D (2,000) 8,480     -
   Thompson Tommy G   –       •      –    2024-03-01 4 OE $88.03 $176,060 D/D 2,000 10,480     -
   Kurzweil Ray   –       •      –    2024-02-23 4 D $227.03 $3,405,450 D/D (15,000) 11,180     -
   Kurzweil Ray   –       •      –    2024-02-23 4 OE $88.03 $1,320,450 D/D 15,000 26,180     -
   Thompson Tommy G   –       •      –    2024-02-23 4 D $227.03 $454,060 D/D (2,000) 8,480     -
   Thompson Tommy G   –       •      –    2024-02-23 4 OE $88.03 $176,060 D/D 2,000 10,480     -
   Patusky Christopher   –       •      –    2024-02-23 4 S $224.00 $376,320 D/D (1,680) 4 -18%     
   Mahon Paul A EVP & GENERAL COUNSEL   •       –      –    2024-02-15 4 AS $214.54 $1,291,885 D/D (6,000) 36,599 27%     
   Mahon Paul A EVP & GENERAL COUNSEL   •       –      –    2024-02-15 4 OE $117.76 $706,560 D/D 6,000 42,599     -
   Mahon Paul A EVP & GENERAL COUNSEL   •       –      –    2024-02-01 4 AS $213.58 $1,290,083 D/D (6,000) 36,599 26%     
   Mahon Paul A EVP & GENERAL COUNSEL   •       –      –    2024-02-01 4 OE $117.76 $706,560 D/D 6,000 42,599     -
   Mahon Paul A EVP & GENERAL COUNSEL   •       –      –    2024-01-18 4 AS $217.55 $1,312,322 D/D (6,000) 36,599 25%     

  5060 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 7 of 203
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed